blog navigation

blog posts

  • New lymphoma treatment shows promise in dogs

    After promising trials in mice, the researchers tested their compound, called S-PAC-1, on dogs. The drug arrested tumor growth in three of six dogs with lymphoma, and induced partial remission of tumors in a fourth, with minimal side effects. This dog, a Walker Tree Hound named Hoover, is a healthy research dog used to help determine the best dosing strategy for S-PAC-1. (Veterinary clinical medicine professor Tim Fan adopted Hoover at the completion of the study.)

    After promising trials in mice, the researchers tested their compound, called S-PAC-1, on dogs. The drug arrested tumor growth in three of six dogs with lymphoma, and induced partial remission of tumors in a fourth, with minimal side effects. This dog, a Walker Tree Hound named Hoover, is a healthy research dog used to help determine the best dosing strategy for S-PAC-1. (Veterinary clinical medicine professor Tim Fan adopted Hoover at the completion of the study.)

    Photo by L. Brian Stauffer

    Images

    • Close

      After promising trials in mice, the researchers tested their compound, called S-PAC-1, on dogs. The drug arrested tumor growth in three of six dogs with lymphoma, and induced partial remission of tumors in a fourth, with minimal side effects. This dog, a Walker Tree Hound named Hoover, is a healthy research dog used to help determine the best dosing strategy for S-PAC-1. (Veterinary clinical medicine professor Tim Fan adopted Hoover at the completion of the study.)

      Photo by L. Brian Stauffer

      PrevNext
    • Close

      Tim Fan, a professor of veterinary clinical medicine, left, and chemistry professor Paul Hergenrother, (with a research dog, Hoover) led a study of a compound that shows promise in treating lymphoma in dogs.

      Photo by L. Brian Stauffer

      PrevNext

blog posts